Table 3.
ROC analysis of concentration ratio of metabolites/caffeine
| Healthy Control vs. Nonsevere ALD |
Nonsevere ALD vs. Severe AH |
|||||
|---|---|---|---|---|---|---|
| P Value | AUC | 95% CI | P Value | AUC | 95% CI | |
| 137U | <0.001 | 0.865 | 0.735–0.994 | 0.181 | 0.625 | 0.438–0.812 |
| 1X | 0.002 | 0.795 | 0.646–0.944 | 0.009 | 0.733 | 0.580–0.885 |
| 1U | 0.001 | 0.833 | 0.678–0.989 | 0.575 | 0.553 | 0.371–0.734 |
| 17U | <0.001 | 0.900 | 0.789–1.000 | 0.013 | 0.736 | 0.573–0.899 |
| 3U | 0.006 | 0.796 | 0.626–0.965 | 0.800 | 0.526 | 0.316–0.736 |
| 7U | 0.001 | 0.837 | 0.699–0.976 | 0.038 | 0.703 | 0.541–0.865 |
| 17X | <0.001 | 0.901 | 0.803–0.999 | 0.008 | 0.737 | 0.582–0.892 |
| 37U | 0.003 | 0.821 | 0.665–0.976 | 0.603 | 0.556 | 0.347–0.764 |
| AAMU | 0.001 | 0.841 | 0.695–0.988 | 0.005 | 0.819 | 0.655–0.982 |
| 13U | 0.001 | 0.830 | 0.682–0.978 | 0.252 | 0.612 | 0.422–0.802 |
| 7X | 0.003 | 0.804 | 0.658–0.949 | 0.068 | 0.679 | 0.503–0.854 |
| 3X | 0.015 | 0.752 | 0.585–0.918 | 0.482 | 0.569 | 0.389–0.748 |
| 37X | 0.032 | 0.709 | 0.537–0.881 | 0.848 | 0.518 | 0.337–0.698 |
| 13X | 0.261 | 0.607 | 0.423–0.791 | 0.353 | 0.583 | 0.405–0.761 |
ALD, alcohol-associated liver disease; AH, alcohol-associated hepatitis; AUC, area under the curve; CI, confidence interval; ROC, receiver operating characteristic.